The effect of bitter gourd (Momordica charantia) ethanolic extract on inflammatory infiltrates and NF-κB activation in periodontitis

https://doi.org/10.22146/majkedgiind.31579

Aryudhi Armis(1*), Tetiana Haniastuti(2), Heni Susilowati(3)

(1) Dental Nursing Study Program, Health Polytechnic of the Ministry of Health of Tanjung Karang, Lampung Master of Dental Sciences, Faculty of Dentistry, Universitas Gadjah Mada, Yogyakarta
(2) Department of Oral Biology, Faculty of Dentistry, Universitas Gadjah Mada, Yogyakarta
(3) Department of Oral Biology, Faculty of Dentistry, Universitas Gadjah Mada, Yogyakarta
(*) Corresponding Author

Abstract


Periodontitis is a periodontal disease involving the gingiva, periodontal ligament, cementum, and alveolar bone due to an inflammatory process. Virulence factors of periodontopathogens and inflammatory responses in periodontitis can stimulate nuclear factor-kappa B (NF-κB) activity. Charantoside c and Momordicosides g in bitter gourd prevent NF-κB activation stimulated by TNF-α in HepG2 cells. This study aims to determine the effect of bitter gourd fruit (Momordica charantia) ethanolic extract as an anti-inflammatory substance on the level of inflammatory infiltrates and the number of cells that experience NF-κB activation in the periodontitis model. Eighty male Wistar rats were divided into 5 groups. The mandibular incisors were ligated for 14 days to induce periodontitis. Each group was given Momordica charantia extract of 500 mg/kg BW, 250 mg/kg BW, and 100 mg/kg BW; ibuprofen 100 mg/kg BW; and aquades orally using oral gavage on the day 14. Rat necropsy was carried out on day 1, 3, 5, and 7 after giving the substances. Taking out the lower jaw was done to make tissue preparations followed by staining them with hematoxylin eosin (HE). Immunohistochemical
analysis was performed to observe cells that were positive for NF-κB activation. The results showed a decrease in the density of inflammatory infiltrates in all groups, except for those given aquades. The number of inflammatory cells of
neutrophils, macrophages, and lymphocytes that experienced NF-κB activation showed the most effective decrease in the group of Momordica charantia 500 mg/kg BW, on the 7th day. The conclusion of this study is that ethanolic extract
of Momordica charantia has an anti-inflammatory effect and prevents the activation of NF-kB in rat gingival induced by periodontitis. The highest effect was found at a dose of 500 mg/kg BW on day 7 after giving of extracts.

Keywords


bitter gourd (Momordica charantia); inflammatory infiltrates; NF-κB; periodontitis

Full Text:

PDF


References

1. Mariano FS, Sardi JCO, Doque C, Hofling JF, Goncalves RB. The role of immune system in the development of periodontal disease: a brief review. Rev odonto ciência. 2010; 25(3): 300-305. doi: 10.1590/S1980-65232010000300016

 

2. Bascones A, Gamonal J, Gomes M, Silva A, Gonzales MA. New knowledge of the
pathogenesis of periodontal disease. Quintessence Int. 2004; 35(9): 706-716.

 

3. Carranza FA, Takey HH, Newman MG. Carranza’s Clinical Periodontology. 9ed. WB. Sounders Co. USA; 2006. 97.

 

4. Pimentel SP, Barella GE, Casarin RCV, Cirano FR, Casati MZ, Foglio MA, Figuera GM, Ribeiro FV. Protective effect of topical Cordia verbenaceain a rat periodontitis
model: immune-inflammatory. Antibacterial and Morphometric Assays. BMC Complement Altern Med. 2012; 12: 224. doi: 10.1186/1472-6882-12-224

 

5. Prahasanti C. Immunohistochemical analysis  of NF-κB (p50/p65) in patient with aggressive and chronic periodontitis. Indonesian Journal of Tropical Infectious Desease. 2013; 4(4): 59-64. doi: 10.20473/ijtid.v4i4.235

 

6. Sharma S, Tandon S, Semwal B, Singh K. Momordica charantia Linn.: a comprehensive review on bitter remedy. Journal of Pharmaceutical Research and Opinion. 2011; 1(2): 42 – 47.

 

7. Nhiem NX, Yen PH, Ngan NT, Quang TH, Kiem PV, Minh CV, Tai BH, Cuong NX, Song SB, Kim YH. Inhibition of nuclear transcription factor-κb and activation of peroxisome proliferator-activated receptors in HepG2 cellsby cucurbitane-type
triterpene glycosides from momordica charantia. J Med Food. 2012; 15(4): 369–377. doi: 10.1089/jmf.2011.1766

 

8. Chao CY, Sung PJ, Wang WH, Kuo YH. AntiInflammatory effect of momordica charantia in sepsis mice. Molecules. 2014; 19(8): 12777-12788.                        doi: 10.3390/molecules190812777


9. Kim K, Kim HY. Bitter melon (Momordica charantia) extract suppresses cytokine induced activation of MAPK and NF-κB in pancreatic β - C e l s F o o d S c B i o e c h 2 0 1 1 2 0 2 ) 531-535. doi: 10.1007/s10068-011-0074-x

 

10. Ionel A, Lucaciu O, Moga M, Buhatel D, Ilea A, Tabaran F, Catoi C, Berce C, Toader S, Campian RS. Periodontal disease induced in wistar rats - experimental study, human & veterinary medicine. International Journal of the Bioflux Society. 2015; 7(2): 90-95.

 

11. Gontiya G, Galgali SR. Effect of hyaluronan on periodontitis: a clinical and histological study. J Indian Soc Periodontol. 2012; 16(2): 184-192.                    doi: 10.4103/0972-124X.99260


12. Praptiwi H. Inokulasi bakteri dan pemasangan cincin atau ligatur untuk induksi periodontitis pada tikus. Majalah  Kedokteran  Gigi. 2008; 15(1): 81-84.

 

13. Graves DT, Kang J, Andriankaja O, Wada K, Rosa Jr C. Animal models to study hostbacteria interactions involved in periodontitis. Front Oral Biol. 2012; 15: 117–132. doi: 10.1159/000329675


14. Gehrig JSN, Wilman DE. Foundations of Periodontics for the Dental Hygienist. 3
ed. Philadelphia: Wolters Kluwer Health, Lippincott Williams & Wilkins; 2010. 87-89.

 

15. Arabaci T, Cicek Y, Canakci V, Canakci CF, Ozgoz M, Albayrak M, Keles ON. Immunohistochemical and stereologic analysis of NF-κB Activation in chronic periodontitis. Eur J Dent. 2010; 4: 454-461.

 

16. Ullah M, Showkat M, Ahmed NU, Islam S, Absar N. Evaluation of Momordica charantia L. fruit extract for analgesic and antiinflammatory activities using in vivo assay. Research Journal of Medical Plant. 2012; 6(3): 236-244.                         doi: 10.3923/rjmp.2012.236.244

 

17. Rainsford KD. Ibuprofen: pharmacology, efficacy and safety. Inflammopharmacology. 2009; 17(6): 275-342. doi: 10.1007/s10787-009-0016-x



DOI: https://doi.org/10.22146/majkedgiind.31579

Article Metrics

Abstract views : 20 | views : 20

Refbacks

  • There are currently no refbacks.




Copyright (c) 2019 Majalah Kedokteran Gigi Indonesia

Creative Commons License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.


Currently, Majalah Kedokteran Gigi Indonesia indexed by:

         

 

 

 

 

 

 View My Stats


real
time web analytics